Pretreatments before the induction of ovulation in assisted reproduction technologies: Evidence-based medicine in 2007

Annals of the New York Academy of Sciences

Volumn 1127, Issue , 2008, Pages 31-40

  Bromer, Jason Gabriel ^a   Cetinkaya, Mehmet Bilge ^a   Arici, Aydin ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ART; Aspirin; Corticosteroid; Growth hormone; IVF; Metformin; Oral contraceptive; Pretreatment

Indexed keywords

ACETYLSALICYLIC ACID; BUSERELIN; CETRORELIX; CORTICOSTEROID; ESTRADIOL; ETHINYLESTRADIOL; FOLLITROPIN; GESTAGEN; GLUCOCORTICOID; GONADORELIN AGONIST; GROWTH HORMONE; INSULIN SENSITIZING AGENT; LEVONORGESTREL; METFORMIN; ORAL CONTRACEPTIVE AGENT; PLACEBO; PREDNISONE;

ASSISTED REPRODUCTION TECHNOLOGY; ASSISTIVE TECHNOLOGY; BIRTH RATE; CONFERENCE PAPER; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FERTILIZATION IN VITRO; HUMAN; INCIDENCE; LIVE BIRTH; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION;

EID: 42449157168     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1434.004     Document Type: Conference Paper

References (71)

1. Weckstein, L.N. et al. 1997. Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study. Fertil. Steril. 68 : 927 930.
2. Ziebe, S. et al. 2001. Embryo quality and developmental potential is compromised by age. Acta Obstet. Gynecol. Scand. 80 : 169 174.
3. Terriou, P. et al. 2001. Embryo score is a better predictor of pregnancy than the number of transferred embryos or female age. Fertil. Steril. 75 : 525 531.
4. Ebner, T. et al. 2000. Prognostic value of first polar body morphology on fertilization rate and embryo quality in intracytoplasmic sperm injection. Hum. Reprod. 15 : 427 430.
5. Tomas, C. et al. 2002. The degree of difficulty of embryo transfer is an independent factor for predicting pregnancy. Hum. Reprod. 17 : 2632 2635.
6. Sher, G. et al. 1994. High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum. Reprod. 9 : 2278 2283.
7. Shanbhag, S. et al. 2007. Interventions for "poor responders" to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst. Rev. CD004379.
8. Boomsma, C.M. et al. 2007. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst. Rev. CD005996.
9. Harper, K. et al. 2003. Growth hormone for in vitro fertilization. Cochrane Database Syst. Rev. CD000099.
10. Biljan, M.M. et al. 1998. Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues. J. Assist. Reprod. Genet. 15 : 599 604.
11. Howles, C.M. et al. 1999. Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization? Hum. Reprod. 14 : 1939 1943.
12. Pedersen, A.K. & G.A. FitzGerald. 1985. Preparation and analysis of deuterium-labeled aspirin: application to pharmacokinetic studies. J. Pharm. Sci. 74 : 188 192.
13. FitzGerald, G.A. & J.A. Oates. 1984. Selective and nonselective inhibition of thromboxane formation. Clin. Pharmacol. Ther. 35 : 633 640.
14. Bassil, S. et al. 1997. The relationship between ovarian vascularity and the duration of stimulation in in-vitro fertilization. Hum. Reprod. 12 : 1240 1245.
15. Weiner, Z. et al. 1993. Assessment of ovarian and uterine blood flow by transvaginal color Doppler in ovarian-stimulated women: correlation with the number of follicles and steroid hormone levels. Fertil. Steril. 59 : 743 749.
16. Pellicer, A. et al. 1994. Aetiological factors involved in the low response to gonadotrophins in infertile women with normal basal serum follicle stimulating hormone levels. Hum. Reprod. 9 : 806 811.
17. Battaglia, C. et al. 2000. Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders. Fertil. Steril. 74 : 809 812.
18. Steer, C.V. et al. 1992. The use of transvaginal color flow imaging after in vitro fertilization to identify optimum uterine conditions before embryo transfer. Fertil. Steril. 57 : 372 376.
19. Rubinstein, M. et al. 1999. Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay. Fertil. Steril. 71 : 825 829.
20. Lockwood, C.J. & J.H. Rand. 1994. The immunobiology and obstetrical consequences of antiphospholipid antibodies. Obstet. Gynecol. Surv. 49 : 432 441.
21. Stern, C. & L. Chamley. 2006. Antiphospholipid antibodies and coagulation defects in women with implantation failure after IVF and recurrent miscarriage. Reprod. Biomed. Online 13 : 29 37.
22. Birdsall, M.A. et al. 1996. Antiphospholipid antibodies in women having in-vitro fertilization. Hum. Reprod. 11 : 1185 1189.
23. Gleicher, N. 2001. Antiphospholipid antibodies (aPL) affect in vitro fertilization (IVF) outcome. Am. J. Reprod. Immunol. 46 : 330 331.
24. Geva, E. et al. 2000. Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective study. Am. J. Reprod. Immunol. 43 : 36 40.
25. Strehler E. et al. 2002. Prednisone plus aspirin has no significant effect on pregnancy rates in IVF/ICSI cycles. Abstracts of the 18th Annual Meeting of the ESHRE, Vienna, Austria, 117.
26. Khairy, M. et al. 2007. Aspirin in women undergoing in vitro fertilization treatment: a systematic review and meta-analysis. Fertil. Steril. 88 (4 822 831.
27. Gelbaya, T.A. et al. 2007. Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis. Hum. Reprod. Update 13 : 357 364.
28. Lok, I.H. et al. 2004. Adjuvant low-dose aspirin therapy in poor responders undergoing in vitro fertilization: a prospective, randomized, double-blind, placebo-controlled trial. Fertil. Steril. 81 : 556 561.
29. Al-Inany, H. & M. Aboulghar. 2002. GnRH antagonist in assisted reproduction: a Cochrane review. Hum. Reprod. 17 : 874 885.
30. Tsai, C.C. & S.S. Yen. 1971. The effect of ethinyl estradiol administration during early follicular phase of the cycle on the gonadotropin levels and ovarian function. J. Clin. Endocrinol. Metab. 33 : 917 923.
31. le Nestour, E. et al. 1993. Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition. J. Clin. Endocrinol. Metab. 77 : 439 442.
32. Fanchin, R. et al. 2003. Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum. Reprod. 18 : 2698 2703.
33. Anderson, R.E. et al. 1990. Effects of norethindrone on gonadotropin and ovarian steroid secretion when used for cycle programming during in vitro fertilization. Fertil. Steril. 54 : 96 101.
34. Cedrin-Durnerin, I. et al. 1996. The hormonal flare-up following gonadotrophin-releasing hormone agonist administration is influenced by a progestogen pretreatment. Hum. Reprod. 11 : 1859 1863.
35. Frydman, R. et al. 1986. A new approach to follicular stimulation for in vitro fertilization: programmed oocyte retrieval. Fertil. Steril. 46 : 657 662.
36. Biljan, M.M. et al. 1998. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates. Fertil. Steril. 70 : 1063 1069.
37. Van Heusden, A.M. & B.C. Fauser. 1999. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives. Contraception 59 : 237 243.
38. de Ziegler, D. et al. 1998. Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH). Hum. Reprod. 13 : 561 564.
39. Fanchin, R. et al. 2003. Luteal estradiol administration strengthens the relationship between day 3 follicle-stimulating hormone and inhibin B levels and ovarian follicular status. Fertil. Steril. 79 : 585 589.
40. Huirne, J.A. et al. 2006. Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF/ICSI patients treated with r-hFSH: a randomized, multicentre, phase IIIb study. Hum. Reprod. 21 : 1408 1415.
41. Huirne, J.A. et al. 2006. Effect of an oral contraceptive pill on follicular development in IVF/ICSI patients receiving a GnRH antagonist: a randomized study. Reprod. Biomed. Online 13 : 235 245.
42. Barmat, L.I. et al. 2005. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization. Fertil. Steril. 83 : 321 330.
43. Fischl F. et al. 2001. Zeitliche optimierung der kontrollierten hyperstimulation (KOH) in kombination mit GnRH-antagonisten und ovulationshemmer in einem IVF programm. J. Fertil. Reprod. 11 : 50 51.
44. Gonen, Y. et al. 1990. Gonadotropin suppression with oral contraceptives before in vitro fertilization. Fertil. Steril. 53 : 282 287.
45. Mashiach, S. et al. 1988. Protocols for induction of ovulation. The concept of programmed cycles. Ann. N. Y. Acad. Sci. 541 : 37 45.
46. Benadiva, C.A. et al. 1988. An increased initial follicle-stimulating hormone/luteinizing hormone ratio does not affect ovarian responses and the outcomes of in vitro fertilization. Fertil. Steril. 50 : 777 781.
47. Check, J.H. et al. 1990. Ovulation induction and pregnancies in 100 consecutive women with hypergonadotropic amenorrhea. Fertil. Steril. 53 : 811 816.
48. Kolibianakis, E.M. et al. 2006. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum. Reprod. 21 : 352 357.
49. Lindheim, S.R. et al. 1996. Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation. J. Assist. Reprod. Genet. 13 : 745 747.
50. Rombauts, L. et al. 2006. A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients. Hum. Reprod. 21 : 95 103.
51. Palomba, S. et al. 2006. Use of oral contraceptives in infertile patients: a descriptive review. Gynecol. Endocrinol. 22 : 537 546.
52. Cedrin-Durnerin, I. et al. 2007. Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. Hum. Reprod. 22 : 109 116.
53. Langford, K.S. & J.P. Miell. 1993. The insulin-like growth factor-I/binding protein axis: physiology, pathophysiology and therapeutic manipulation. Eur. J. Clin. Invest. 23 : 503 516.
54. Adashi, E.Y. et al. 1985. Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr. Rev. 6 : 400 420.
55. Erickson, G.F. et al. 1989. Insulin-like growth factor-I regulates aromatase activity in human granulosa and granulosa luteal cells. J. Clin. Endocrinol. Metab. 69 : 716 724.
56. Yoshimura, Y. et al. 1996. Interactions between insulin-like growth factor-I (IGF-I) and the renin-angiotensin system in follicular growth and ovulation. J. Clin. Invest. 98 : 308 316.
57. Hugues, J.N. et al. 1991. Interest of growth hormone-releasing hormone administration for improvement of ovarian responsiveness to gonadotropins in poor responder women. Fertil. Steril. 55 : 945 951.
58. Bachelot, A. et al. 2002. Growth hormone is required for ovarian follicular growth. Endocrinology 143 : 4104 4112.
59. Tesarik, J. et al. 2005. Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormone. Hum. Reprod. 20 : 2536 2541.
60. Dunaif, A. et al. 1992. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41 : 1257 1266.
61. Utiger, R.D. 1996. Insulin and the polycystic ovary syndrome. N. Engl. J. Med. 335 : 657 658.
62. Yarali, H. & H.B. Zeyneloglu. 2004. Gonadotrophin treatment in patients with polycystic ovary syndrome. Reprod. Biomed. Online 8 : 528 537.
63. Aboulghar, M.A. & R.T. Mansour. 2003. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum. Reprod. Update 9 : 275 289.
64. Bailey, C.J. & R.C. Turner. 1996. Metformin. N. Engl. J. Med. 334 : 574 579.
65. Piacquadio, K. et al. 1991. Effects of in-utero exposure to oral hypoglycaemic drugs. Lancet 338 : 866 869.
66. Stadtmauer, L.A. et al. 2001. Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertil. Steril. 75 : 505 509.
67. Fedorcsák, P. et al. 2003. The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: an open-label randomized cross-over trial. Gynecol. Endocrinol. 17 : 207 214.
68. Kjotrod, S.B. et al. 2004. Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study. Hum. Reprod. 19 : 1315 1322.
69. Onalan, G. et al. 2005. Metformin treatment in patients with polycystic ovary syndrome undergoing in vitro fertilization: a prospective randomized trial. Fertil. Steril. 84 : 798 801.
70. Tang, T. et al. 2006. The use of metformin for women with PCOS undergoing IVF treatment. Hum. Reprod. 21 : 1416 1425.
71. Doldi, N. et al. 2006. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer. Gynecol. Endocrinol. 22 : 235 238.